Get the Stockscreener App
86.12
0.42%
-0.36
After Hours:
86.50
0.38
+0.44%
Overview
News
Price History
Option Chain
Financials
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co stock is traded at $86.12, with a volume of 3.67M.
It is down -0.42% in the last 24 hours and down -14.85% over the past month.
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
See More
Previous Close:
$86.48
Open:
$86.3
24h Volume:
3.67M
Relative Volume:
1.43
Market Cap:
$10.41B
Revenue:
$6.76B
Net Income/Loss:
$770.00M
P/E Ratio:
13.99
EPS:
6.1566
Net Cash Flow:
$380.00M
1W Performance:
-10.85%
1M Performance:
-14.85%
6M Performance:
-20.93%
1Y Performance:
-37.77%
1-Day Range:
$84.70
$86.97
1-Week Range:
$84.70
$96.92
52-Week Range:
$84.70
$138.94
Clorox Co Stock (CLX) Company Profile
Name
Clorox Co
Sector
Industry
Phone
(510) 271-7000
Address
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
86.12 | 10.46B | 6.76B | 770.00M | 380.00M | 6.1566 |
PG
Procter Gamble Co
|
144.90 | 333.97B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.42 | 128.22B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
86.33 | 68.31B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
17.37 | 32.93B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
97.20 | 31.75B | 16.56B | 1.75B | 1.84B | 6.36 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-11-26 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Oct-01-25 | Reiterated | Barclays | Underweight |
| Jan-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-06-24 | Upgrade | TD Cowen | Sell → Hold |
| Oct-01-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-23-24 | Initiated | TD Cowen | Sell |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Apr-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Mar-26-24 | Upgrade | Jefferies | Underperform → Hold |
| Mar-01-24 | Resumed | Goldman | Sell |
| Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
| Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-13-23 | Initiated | Jefferies | Underperform |
| Nov-06-23 | Upgrade | UBS | Sell → Neutral |
| Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Hold |
| Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Feb-17-23 | Initiated | Citigroup | Neutral |
| Oct-18-22 | Initiated | Evercore ISI | Underperform |
| Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-14-22 | Resumed | BofA Securities | Underperform |
| Jul-13-22 | Initiated | Raymond James | Outperform |
| Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
| Feb-04-22 | Reiterated | Deutsche Bank | Hold |
| Feb-04-22 | Reiterated | JP Morgan | Underweight |
| Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
| Feb-04-22 | Reiterated | UBS | Sell |
| Feb-04-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
| Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-02-21 | Reiterated | DA Davidson | Neutral |
| Nov-02-21 | Reiterated | Deutsche Bank | Hold |
| Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-02-21 | Reiterated | Wells Fargo | Underweight |
| Sep-03-21 | Downgrade | Argus | Buy → Hold |
| Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Aug-04-21 | Reiterated | Citigroup | Buy |
| Aug-04-21 | Reiterated | Credit Suisse | Neutral |
| Aug-04-21 | Reiterated | Deutsche Bank | Hold |
| Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
| Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-04-21 | Reiterated | UBS | Sell |
| Aug-04-21 | Reiterated | Wells Fargo | Underweight |
| Jun-24-21 | Initiated | UBS | Sell |
| May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-20 | Initiated | DA Davidson | Buy |
| Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
| Mar-09-20 | Upgrade | Argus | Hold → Buy |
| Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
| Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
| May-20-19 | Downgrade | Argus | Buy → Hold |
| May-02-19 | Reiterated | BofA/Merrill | Neutral |
| May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
| Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-07-19 | Initiated | Credit Suisse | Outperform |
| Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
| Sep-25-18 | Upgrade | Argus | Hold → Buy |
| Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
| Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-08-18 | Downgrade | Argus | Buy → Hold |
| Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co Stock (CLX) Latest News
Insider Buying: Clorox (NYSE:CLX) Director Purchases 5,000 Shares of Stock - MarketBeat
Trust for Clorox (NYSE: CLX) director buys 5,000 company shares - Stock Titan
Why Clorox (CLX) Is Down 10.5% After Cutting 2026 Outlook And Planning New Debt Issuance - simplywall.st
Clorox: Undervalued Near Dividend King, And A Possible Even Better Strategy (NYSE:CLX) - Seeking Alpha
The Clorox Company Shareholders Are Encouraged to Reach Out - GlobeNewswire
Is Clorox Stock Worth Watching Right Now - Kalkine Media
Clorox Co. stock underperforms Friday when compared to competitors - MSN
Clorox (NYSE:CLX) Hits New 1-Year Low Following Analyst Downgrade - MarketBeat
Clorox Shares Offer Bullish Opportunity Amid Dividend Growth History - HarianBasis.co
Three Profitable Companies That May Face Long-Term Challenges - IndexBox
Wilkins Investment Counsel Inc. Boosts Stake in The Clorox Company $CLX - MarketBeat
M&T Bank Corp Has $421,000 Position in The Clorox Company $CLX - MarketBeat
Why Clorox (CLX) Shares Are Getting Obliterated Today - Yahoo Finance
Clorox (CLX) Q3 2026 Net Margin Expansion Tests Bullish ERP Efficiency Narrative - simplywall.st
SanDisk, Western Digital, Clorox And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
Clorox Stock Sinks After Outlook Cut: Why the Bleach Maker’s Profit Squeeze Isn’t Over - TechStock²
Penn Series Large Core Value Fund's Clorox Co(CLX) Holding History - GuruFocus
The Clorox Company (NYSE:CLX) Q3 2026 Earnings Call Transcript - Insider Monkey
Clorox Earnings: Cost Pressures Dent Profits, but Prudent Brand Spending Persists; Shares Attractive - Morningstar
The Clorox Company Q3 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
Is Clorox Co (CLX) a Bargain After 9.7% Drop? GF Value Says Unde - GuruFocus
Clorox’s Purell Deal Expands Health Focus As Earnings Outlook Softens - simplywall.st
Clorox (NYSE:CLX) Given New $97.00 Price Target at Citigroup - MarketBeat
These Analysts Lower Their Forecasts On Clorox Following Q3 EarningsClorox (NYSE:CLX) - Benzinga
CLXClorox Co Stock Price and Quote - Finviz
Clorox (NYSE:CLX) Price Target Lowered to $95.00 at JPMorgan Chase & Co. - MarketBeat
Clorox (CLX) Faces Challenges with Mixed Q3 Results and Downgraded Outlook - GuruFocus
TD Cowen cuts Clorox stock price target on guidance cut, ERP issues - Investing.com India
Clorox (NYSE:CLX) Shares Gap Down Following Analyst Downgrade - MarketBeat
Morgan Stanley Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price - MarketBeat
Clorox stock hits 52-week low at $91.00 amid challenging year - Investing.com
Vanguard Group Inc. Lowers Stock Position in The Clorox Company $CLX - MarketBeat
MSN Money - MSN
UBS cuts Clorox stock price target on weaker guidance outlook - Investing.com
Morgan Stanley cuts Clorox stock price target on sales struggles By Investing.com - Investing.com India
Evercore ISI cuts Clorox stock price target on margin pressures - Investing.com
Evercore ISI cuts Clorox stock price target on margin pressures By Investing.com - Investing.com Canada
Goldman Sachs cuts Clorox stock price target on guidance reduction - Investing.com
Goldman Sachs cuts Clorox stock price target on guidance reduction By Investing.com - Investing.com UK
Clorox Co. Stock Plummets to New 52-Week Low at $93.42 - Markets Mojo
CLX Stock Price, Quote & Chart | CLOROX COMPANY (NYSE:CLX) - ChartMill
Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovations By GuruFocus - Investing.com Canada
Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Cha - GuruFocus
CLX SWOT Analysis: Key Insights from Q2 2026 10-Q Filing - GuruFocus
Clorox Sees Margin Hit from Middle East Conflict, Consumer Pressure - CookOut News
Clorox (CLX) Q3 FY2026: EPS $1.54 vs $1.51 Est (Beat), Revenue $ - GuruFocus
Clorox (CLX) Revises Gross Margin Projections Amid Various Headw - GuruFocus
CLX Sees Decline in Gross Margin Amid Rising Costs - GuruFocus
Clorox (NYSE: CLX) registers shelf for senior debt securities to issue as needed - Stock Titan
Earnings call transcript: Clorox Q3 2026 beats EPS estimates amid mixed results - Investing.com
Clorox (NYSE:CLX) Releases FY 2026 Earnings Guidance - MarketBeat
Clorox Co Stock (CLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.93%
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):